PureTech Health plcHere is the public summary page for PureTech Health plc. Please login to see the complete information for PureTech Health plc including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how PureTech Health plc stacks up relative to its peers. |
| Darwin Score | +6 |
| Ticker | PRTC |
| Latest Price | 1.43 GBX as of close on 25-Jul-2025 |
| 3 Month price range | 1.22 to 1.44 GBX |
| Market Capitalisation | 343.08Mn GBX |
| Country | UK |
| Region | Europe |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Life Sciences Tools & Services |
| Sub-Industry | Life Sciences Tools & Services |
| Description | PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. It is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies. The company also develops SPT-300, an oral drug of allopregnanolone for the treatment of anxious depression; and delivers transformative medicines for patients with psychiatric and neurological conditions. In addition, the company develops hydrogels to enable the oral administration of peptide therapeutics in preclinical development; oral therapies based on defined bacterial consortia that is in phase 3 clinical stage; and engineering hematopoietic stem cells to enable targeted therapies for patients with blood cancers. Further, it develops voice-based technology platform that detects changes in the sound of voice that are linked with health conditions, including depression, anxiety, and respiratory disease. The company was incorporated in 2015 and is based in Boston, Massachusetts. See More ... |
| Company URL | https://www.puretechhealth.com |
| See Darwins Full Analysis for PureTech Health plc |
Tell Me About
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for PureTech Health plc. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | +21 |
| Sentiment | News and Candle Patterns. | -1 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | -5 |
| Flow | Institutional, Fund and Insider buying and selling. | 0 |
| Models | Forecast models. | -9 |
Alerts
There are 6 live alerts for PureTech Health plc.
- Overbought - The 15 day RSI is +72.7. (Negative)
- Overbought - The 5 week RSI is +84.7. (Negative)
- Candle Pattern :: Inverted Hammer (Bearish) (Negative) (Negative)
- 15d RSI Overbought. This alert has occurred 9 times over the last last year. The average forward returns are -6.0% over 5 days, -7.5% over 10 days, -8.0% over 15 days and -7.7% over 20 days. (Positive)
- 5d RSI Overbought. This alert has occurred 54 times over the last last year. The average forward returns are -1.5% over 5 days, -1.9% over 10 days, -2.2% over 15 days and -2.9% over 20 days. (Positive)
- Technically Overbought - 14 day RSI above 70. This alert has occurred 10 times over the last last year. The average forward returns are -5.2% over 5 days, -7.6% over 10 days, -8.0% over 15 days and -7.7% over 20 days. (Positive)
Peer Comparison
There are 2 peers of PureTech Health plc.
| Asset Name | Industry Group | Asset Score |
|---|---|---|
| IXICO PLC (IXI) | Life Sciences Tools & Services | +33 |
| Oxford Biodynamics PLC (OBD) | Life Sciences Tools & Services | -20 |
Share 
